The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot study on cisplatin-based transarterial chemoembolization combined with systemic cisplatin plus gemcitabine for advanced or metastatic intrahepatic cholangiocellular carcinoma.
 
Sadahisa Ogasawara
Honoraria - Bayer
Consulting or Advisory Role - Bayer; Eisai
 
Yoshihiko Ooka
No Relationships to Disclose
 
Eiichiro Suzuki
No Relationships to Disclose
 
Harutoshi Sugiyama
No Relationships to Disclose
 
Akinobu Tawada
No Relationships to Disclose
 
Yuji Sakai
No Relationships to Disclose
 
Tetsuhiro Chiba
No Relationships to Disclose
 
Fumihiko Kanai
No Relationships to Disclose
 
Toshio Tsuyuguchi
No Relationships to Disclose
 
Osamu Yokosuka
Honoraria - Abbott; Ajinomoto; Bayer; Bristol-Myers Squibb; Chugai Pharma; Dainippon Sumitomo Pharma; Given Imaging; GlaxoSmithKline; Kowa; Merck Sharp & Dohme; Mitsubishi Tanabe Pharma; Sysmex
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Astellas Pharma; Bayer; Chugai Pharma; Daiichi Sankyo; Dainippon Sumitomo Pharma; Eisai; Merck Sharp & Dohme; Mitsubishi Tanabe Pharma; Otsuka; Takeda